MDVLQ (MedAvail Holdings) EBITDA Margin %: -1,214.57% (As of Jun. 2023)


MDVLQ MedAvail Holdings Inc MDVLQ
12 GF Score
Price $0.00
View Full Analysis

What is MedAvail Holdings EBITDA Margin %?

MedAvail Holdings MDVLQ 12 EBITDA Margin % is -1,214.57% as of Jun. 2023. GuruFocus rates MDVLQ with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedAvail Holdings's EBITDA for the three months ended in Jun. 2023 was $-4.92 Mil. MedAvail Holdings's Revenue for the three months ended in Jun. 2023 was $0.41 Mil. Therefore, MedAvail Holdings's EBITDA margin for the quarter that ended in Jun. 2023 was -1,214.57%.

MedAvail Holdings  (OTCPK:MDVLQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MedAvail Holdings EBITDA Margin % Related Terms

MedAvail Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings EBITDA Margin % Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
-508.01 -170.13 -183.68 -96.88

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -822.47 -84.73 -80.35 -1,855.65 -1,214.57

MDVLQ vs HEWA, BIMI, MEDS: EBITDA Margin % Comparison

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedAvail Holdings EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's EBITDA Margin % falls into.


MDVLQ
12GF Score
MedAvail Holdings Inc MDVLQ
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MedAvail Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-41.765/43.109
=-96.88 %

MedAvail Holdings's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-4.919/0.405
=-1,214.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,214.57% mean?
MedAvail Holdings (MDVLQ) has a EBITDA Margin % of -1,214.57% as of Jun. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedAvail Holdings and its competitors.
Is MedAvail Holdings' EBITDA Margin % too high?
MedAvail Holdings' current EBITDA Margin % is -1,214.57%. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' EBITDA Margin % compare to HEWA and BIMI?
MedAvail Holdings' EBITDA Margin % of -1,214.57% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedAvail Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedAvail Holdings's current EBITDA Margin % is -1,214.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (MDVLQ) has a current EBITDA Margin % of -1,214.57%. The current EBITDA Margin % is -1,214.57%. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MedAvail Holdings (MDVLQ), the current EBITDA Margin % is -1,214.57% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for MDVLQ

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price